Literature DB >> 1316947

Two patterns of persistence of herpes simplex virus DNA sequences in the nervous systems of latently infected mice.

A Simmons1, B Slobedman, P Speck, J Arthur, S Efstathiou.   

Abstract

The number of herpes simplex virus (HSV) genome equivalents recovered from latently infected mouse spinal ganglia was compared with the proportion of neurons containing latency-associated transcripts (LATs). Two distinct patterns of HSV persistence were observed, depending on the anatomical location of ganglia with respect to the site of cutaneous inoculation. The location of the bulk of latent viral DNA did not correspond with the highest prevalence of LAT+ neurons. Viral DNA was most abundant in spinal ganglia directly innervating the inoculation site and the amount recovered, which was similar to that found previously in human trigeminal ganglia, suggested that LAT+ neurons each contain hundreds of copies of HSV DNA. In stark contrast, although LAT+ neurons were most abundant in neighbouring ganglia, viral DNA was scarce (approx. 20 copies/LAT+ cell). These data indicate that amplification of HSV DNA sequences is greatest in ganglia previously shown to be associated with viral antigen expression during the productive phase of primary infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316947     DOI: 10.1099/0022-1317-73-5-1287

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo.

Authors:  R L Thompson; May T Shieh; N M Sawtell
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 3.  Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

4.  Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level.

Authors:  Kening Wang; Tsz Y Lau; Melissa Morales; Erik K Mont; Stephen E Straus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  The herpes simplex virus type 1 latency-associated transcript promoter is activated through Ras and Raf by nerve growth factor and sodium butyrate in PC12 cells.

Authors:  D P Frazier; D Cox; E M Godshalk; P A Schaffer
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 6.  Animal models of herpes simplex virus immunity and pathogenesis.

Authors:  Christina M Kollias; Richard B Huneke; Brian Wigdahl; Stephen R Jennings
Journal:  J Neurovirol       Date:  2014-11-12       Impact factor: 2.643

7.  Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia.

Authors:  Martha F Kramer; Igor Jurak; Jean M Pesola; Sandrine Boissel; David M Knipe; Donald M Coen
Journal:  Virology       Date:  2011-07-23       Impact factor: 3.616

8.  The herpes simplex virus type 1 immediate-early protein ICP0 is necessary for the efficient establishment of latent infection.

Authors:  C L Wilcox; R L Smith; R D Everett; D Mysofski
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2.

Authors:  S W French; M C Schmidt; J C Glorioso
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  De Novo Herpes Simplex Virus VP16 Expression Gates a Dynamic Programmatic Transition and Sets the Latent/Lytic Balance during Acute Infection in Trigeminal Ganglia.

Authors:  Nancy M Sawtell; Richard L Thompson
Journal:  PLoS Pathog       Date:  2016-09-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.